European urology Journal

Overview
Identity
View All

publication venue for

Epidemiology of Renal Cell Carcinoma: 2022 Update.. 82:529-542. 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.. 81:414-425. 2022
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.. 81:576-585. 2021
Reply to Kenta Ushida, Miho Shimizu, and Ryo Momosaki's Letter to the Editor re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015. Strategies for Effective Prehabilitation in Urologic Cancer.. 80:e141-e142. 2021
The European Urology Commitment to Gender Equity and Diversity: Expanding Cognitive Diversity through Inclusivity at the Podium.. 80:450-453. 2021
Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review.. 81:157-167. 2021
Advances in the Characterization of Clear Cell Papillary Renal Cell Carcinoma: Identifying the Sheep in Wolf's Clothing.. 79:478-479. 2021
Female Authorship Trends in Urology During the COVID-19 Pandemic.. 79:322-324. 2020
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.. 74:575-582. 2018
Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.. 71:340-348. 2016
Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.. 68:e84-5. 2015
Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.. 68:480-6. 2015
Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers.. 68:205-6. 2014
Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.. 67:e21-2. 2014
Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.. 67:e24-5. 2014
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.. 67:252-9. 2014
Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.. 63:486-92. 2012
A comparison of postoperative complications in open versus robotic cystectomy.. 57:274-81. 2009